Press Release, EIN Presswire Örn Almarsson 9/9/26 Press Release, EIN Presswire Örn Almarsson 9/9/26 ‘Axelyf and Mote Therapeutics Form Alliance to Provide Off-the-Shelf In Vivo T-Cell Targeted Delivery for Nucleic Acids’ Read More Press Release, EIN Presswire Örn Almarsson 12/16/25 Press Release, EIN Presswire Örn Almarsson 12/16/25 ‘Axelyf Appoints Daniel Frímannsson, Ph.D., Head of Nucleic Acid Technologies & Biology and Leslie Williams to Board’ Read More Press Release, EIN Presswire Örn Almarsson 8/19/25 Press Release, EIN Presswire Örn Almarsson 8/19/25 ‘Axelyf Closes Seed Financing to Advance Next-Generation RNA-LNP Therapeutics’ Read More
Press Release, EIN Presswire Örn Almarsson 9/9/26 Press Release, EIN Presswire Örn Almarsson 9/9/26 ‘Axelyf and Mote Therapeutics Form Alliance to Provide Off-the-Shelf In Vivo T-Cell Targeted Delivery for Nucleic Acids’ Read More
Press Release, EIN Presswire Örn Almarsson 12/16/25 Press Release, EIN Presswire Örn Almarsson 12/16/25 ‘Axelyf Appoints Daniel Frímannsson, Ph.D., Head of Nucleic Acid Technologies & Biology and Leslie Williams to Board’ Read More
Press Release, EIN Presswire Örn Almarsson 8/19/25 Press Release, EIN Presswire Örn Almarsson 8/19/25 ‘Axelyf Closes Seed Financing to Advance Next-Generation RNA-LNP Therapeutics’ Read More
